tirzepatide health canada A new Breakthrough T1D-funded clinical trial is launching in Canada. Led by Dr. Ahmad Haidar at McGill University, the study will explore whether can help improve automated insulin delivery (AID) systems Tirzepatide GLP-1 Canada | Dual

Wegovy shows superior weight loss (~15% vs ~3%) with equivalent glycemic control

doi: 10.3390/ijms161226225

In 2003, Ruch and colleagues demonstrated good or excellent results with acute repair of the TFCC at the time of distal radius operative treatment in 56 patients, with only 2 patients with transient ulnar dorsal sensory irritation, but they lacked a control group

The class II histone deacetylases as therapeutic targets for Parkinsons disease

What is clear is that the crackdown on compounding is a major win for the drug companies, and telemedicine services will need to play nice with them to keep their GLP-1 supply flowing

Tirzepatide has a roughly 5-day half-life, so there will still be residual drug in your system when you begin sublingual dosing